Mc Collum Christoferson Group LLC Abbott Laboratories Transaction History

Mc Collum Christoferson Group LLC

  • $328 Million
  • Q3 2024

A detailed history of Mc Collum Christoferson Group LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Mc Collum Christoferson Group LLC holds 72,867 shares of ABT stock, worth $8.64 Million. This represents 2.54% of its overall portfolio holdings.

Number of Shares
72,867
Previous 72,297 0.79%
Holding current value
$8.64 Million
Previous $7.51 Million 10.58%
% of portfolio
2.54%
Previous 2.35%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024
BUY
$100.07 - $118.13 $57,039 - $67,334
570 Added 0.79%
72,867 $8.31 Million
Q2 2024

Jul 30, 2024
SELL
$100.73 - $112.44 $215,662 - $240,734
-2,141 Reduced 2.88%
72,297 $7.51 Million
Q1 2024

Apr 26, 2024
SELL
$109.52 - $120.96 $41,727 - $46,085
-381 Reduced 0.51%
74,438 $8.46 Million
Q4 2023

Jan 19, 2024
SELL
$90.19 - $110.4 $45,004 - $55,089
-499 Reduced 0.66%
74,819 $8.24 Million
Q3 2023

Nov 08, 2023
SELL
$95.53 - $114.62 $129,825 - $155,768
-1,359 Reduced 1.77%
75,318 $7.29 Million
Q2 2023

Jul 28, 2023
BUY
$100.78 - $112.29 $68,731 - $76,581
682 Added 0.9%
76,677 $8.36 Million
Q1 2023

May 01, 2023
SELL
$96.86 - $114.01 $180,159 - $212,058
-1,860 Reduced 2.39%
75,995 $7.7 Million
Q4 2022

Feb 06, 2023
BUY
$95.06 - $111.52 $19,107 - $22,415
201 Added 0.26%
77,855 $8.55 Million
Q3 2022

Oct 31, 2022
SELL
$96.76 - $112.03 $79,343 - $91,864
-820 Reduced 1.04%
77,654 $7.51 Million
Q2 2022

Aug 10, 2022
SELL
$102.07 - $123.37 $59,200 - $71,554
-580 Reduced 0.73%
78,474 $8.53 Million
Q1 2022

May 10, 2022
SELL
$114.02 - $139.04 $27,934 - $34,064
-245 Reduced 0.31%
79,054 $9.36 Million
Q4 2021

Feb 09, 2022
BUY
$115.53 - $141.46 $66,545 - $81,480
576 Added 0.73%
79,299 $11.2 Million
Q3 2021

Oct 13, 2021
SELL
$116.66 - $129.06 $1,749 - $1,935
-15 Reduced 0.02%
78,723 $9.3 Million
Q2 2021

Jul 14, 2021
SELL
$105.79 - $124.53 $12,165 - $14,320
-115 Reduced 0.15%
78,738 $9.13 Million
Q1 2021

Apr 22, 2021
BUY
$108.84 - $128.23 $193,735 - $228,249
1,780 Added 2.31%
78,853 $9.45 Million
Q4 2020

Jan 22, 2021
BUY
$105.0 - $114.42 $61,425 - $66,935
585 Added 0.76%
77,073 $8.44 Million
Q3 2020

Oct 22, 2020
SELL
$91.64 - $111.29 $9,255 - $11,240
-101 Reduced 0.13%
76,488 $8.32 Million
Q2 2020

Jul 31, 2020
SELL
$76.57 - $98.0 $4,441 - $5,684
-58 Reduced 0.08%
76,589 $7 Million
Q1 2020

Apr 13, 2020
SELL
$62.82 - $91.86 $10,428 - $15,248
-166 Reduced 0.22%
76,647 $6.05 Million
Q4 2019

Jan 30, 2020
BUY
$78.51 - $87.4 $14,288 - $15,906
182 Added 0.24%
76,813 $6.67 Million
Q3 2019

Oct 17, 2019
SELL
$81.84 - $88.74 $14,976 - $16,239
-183 Reduced 0.24%
76,631 $6.41 Million
Q2 2019

Jul 11, 2019
BUY
$72.88 - $85.0 $5,174 - $6,035
71 Added 0.09%
76,814 $6.46 Million
Q1 2019

Apr 11, 2019
SELL
$66.22 - $80.06 $331 - $400
-5 Reduced 0.01%
76,743 $6.14 Million
Q4 2018

Jan 15, 2019
BUY
$65.56 - $74.27 $19,143 - $21,686
292 Added 0.38%
76,748 $5.55 Million
Q3 2018

Oct 16, 2018
BUY
$60.81 - $73.36 $35,999 - $43,429
592 Added 0.78%
76,456 $5.61 Million
Q2 2018

Jul 24, 2018
BUY
$57.57 - $63.54 $12,665 - $13,978
220 Added 0.29%
75,864 $4.63 Million
Q1 2018

Apr 20, 2018
BUY
$56.27 - $63.62 $49,236 - $55,667
875 Added 1.17%
75,644 $4.53 Million
Q4 2017

Jan 18, 2018
BUY
$53.68 - $57.47 $4.01 Million - $4.3 Million
74,769
74,769 $4.27 Million

Others Institutions Holding ABT

# of Institutions
3,167
Shares Held
1.33B
Call Options Held
8.63M
Put Options Held
7.19M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Mc Collum Christoferson Group LLC Portfolio

Follow Mc Collum Christoferson Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Collum Christoferson Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Collum Christoferson Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email